Establishment of an Anti-acne Vulgaris Evaluation Method Based on TLR2 and TLR4-mediated Interleukin-8 Production

Pichit Suvanprakorn1, Titiporn Tongyen1, Ornjira Prakhongcheep2,3

  • 1Pan Rajdhevee Group Public Co., Ltd., Pathumthani, Thailand.

In Vivo (Athens, Greece)
|October 31, 2019
PubMed
Abstract

Insights

A new cell-based assay measures toll-like receptor 2 and 4 (TLR2/4) activation and interleukin-8 (IL-8) production to evaluate acne treatments. Zinc gluconate effectively reduced IL-8 production, indicating its potential as an anti-acne agent.

Area of Science:

  • Dermatology
  • Immunology
  • Cell Biology

Background:

  • Acne initiation involves toll-like receptor 2 and 4 (TLR2/4) activation and subsequent interleukin-8 (IL-8) production.
  • Existing cell-based assays do not comprehensively evaluate these key acne pathogenesis factors.

Purpose of the Study:

  • To develop and validate a novel cell-based assay for evaluating acne initiation.
  • The assay quantifies TLR2 and TLR4 expression and activation, alongside IL-8 production.

Main Methods:

  • Keratinocyte viability assessed via MTT assay.
  • Interleukin-8 (IL-8) levels measured using ELISA.
  • Toll-like receptor (TLR) expression determined by immunocytochemistry.

Main Results:

  • Lipoteichoic acid (LTA), peptidoglycan (PGN), and lipopolysaccharide (LPS) stimulated IL-8 production.
  • TLR2 and TLR4 inhibitors reduced IL-8 production, confirming pathway involvement.
  • Zinc gluconate significantly suppressed IL-8 production and prevented TLR2/4 upregulation induced by LTA+PGN or LPS.

Conclusions:

  • The developed assay effectively measures key indicators of acne initiation.
  • Quantifying IL-8, TLR2, and TLR4 levels provides a reliable method for evaluating anti-acne treatments.

Related Concept Videos